A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Malaria is one of the most significant causes of childhood mortality, but disease control efforts are threatened by resistance of the Plasmodium parasite to current therapies. Continued progress in combating malaria requires development of new, easy to administer drug combinations with broad-ranging...
Similar Items
-
Conversion of Dihydroorotate to Orotate in Various Species of Plasmodium and Trypanosomatidae
by: Dave, D. M.
Published: (1977) -
The synthesis and evaluation of inhibitors of dihydroorotate dehydrogenase
by: Hirst, Paul Raymond
Published: (2001) -
Información Bibliográfica
by: J.Mª.A.O., J.D.A., J.R.F., A.M.C., J.F.B., J.L.R.M., M.M.L.
Published: (1995-12-01) -
Evaluating Native American Bird Use and Bird Assemblage Variability along the Oregon Coast
by: Bovy, K.M, et al.
Published: (2019) -
Infomación bibliográfica
by: A.M.C., J.L.L.G., P.A.R., J.M.A., J.C.R.S., F.L.G.
Published: (1996-12-01)